BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 32719095)

  • 21. Defective Influenza A Virus RNA Products Mediate MAVS-Dependent Upregulation of Human Leukocyte Antigen Class I Proteins.
    Rahim MMA; Parsons BD; Price EL; Slaine PD; Chilvers BL; Seaton GS; Wight A; Medina-Luna D; Dey S; Grandy SL; Anderson LE; Zamorano Cuervo N; Grandvaux N; Gaglia MM; Kelvin AA; Khaperskyy DA; McCormick C; Makrigiannis AP
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates innate immune signaling to suppress virus replication.
    Lu HL; Liao F
    J Immunol; 2013 Sep; 191(6):3264-76. PubMed ID: 23926323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors.
    Esser-Nobis K; Hatfield LD; Gale M
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15778-15788. PubMed ID: 32571931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WTAP Targets the METTL3 m
    Sacco MT; Bland KM; Horner SM
    J Virol; 2022 Nov; 96(22):e0099722. PubMed ID: 36314819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment of the retinoic acid-inducible gene-I-IFN-β signaling pathway in chronic hepatitis B virus infection.
    Zhao G; An B; Zhou H; Wang H; Xu Y; Xiang X; Dong Z; An F; Yu D; Wang W; Bao S; Xie Q
    Int J Mol Med; 2012 Dec; 30(6):1498-504. PubMed ID: 22992810
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Imam H; Khan M; Gokhale NS; McIntyre ABR; Kim GW; Jang JY; Kim SJ; Mason CE; Horner SM; Siddiqui A
    Proc Natl Acad Sci U S A; 2018 Aug; 115(35):8829-8834. PubMed ID: 30104368
    [No Abstract]   [Full Text] [Related]  

  • 28. [RIG-I mediated hepatic innate immune signaling that controls HCV infection].
    Saito T; Gale M
    Uirusu; 2008 Dec; 58(2):105-15. PubMed ID: 19374189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses.
    Qu L; Lemon SM
    Semin Liver Dis; 2010 Nov; 30(4):319-32. PubMed ID: 20960373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Structural and functional views of the intracellular viral RNA sensor RIG-I].
    Go S; Yoneyama M; Fujita T
    Uirusu; 2008 Dec; 58(2):97-103. PubMed ID: 19374188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NSUN5 Facilitates Viral RNA Recognition by RIG-I Receptor.
    Sun B; Zeng H; Liang J; Zhang L; Hu H; Wang Q; Meng W; Li C; Ye F; Wang C; Zhu J
    J Immunol; 2020 Dec; 205(12):3408-3418. PubMed ID: 33177158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Links between recognition and degradation of cytoplasmic viral RNA in innate immune response.
    Oshiumi H; Mifsud EJ; Daito T
    Rev Med Virol; 2016 Mar; 26(2):90-101. PubMed ID: 26643446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RIG-I enhances interferon-α response by promoting antiviral protein expression in patients with chronic hepatitis B.
    Wu S; Lin J; Fu Y; Ou Q
    Antivir Ther; 2018; 23(7):575-583. PubMed ID: 29790851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate detection of hepatitis B and C virus and viral inhibition of the response.
    Yi Z; Chen J; Kozlowski M; Yuan Z
    Cell Microbiol; 2015 Sep; 17(9):1295-303. PubMed ID: 26243406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N
    Li H; Guo Y; Qi W; Liao M
    Front Immunol; 2022; 13():1031200. PubMed ID: 36582239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. USP27X negatively regulates antiviral signaling by deubiquitinating RIG-I.
    Tao X; Chu B; Xin D; Li L; Sun Q
    PLoS Pathog; 2020 Feb; 16(2):e1008293. PubMed ID: 32027733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RIG-I: a multifunctional protein beyond a pattern recognition receptor.
    Xu XX; Wan H; Nie L; Shao T; Xiang LX; Shao JZ
    Protein Cell; 2018 Mar; 9(3):246-253. PubMed ID: 28593618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus.
    Sato S; Li K; Kameyama T; Hayashi T; Ishida Y; Murakami S; Watanabe T; Iijima S; Sakurai Y; Watashi K; Tsutsumi S; Sato Y; Akita H; Wakita T; Rice CM; Harashima H; Kohara M; Tanaka Y; Takaoka A
    Immunity; 2015 Jan; 42(1):123-32. PubMed ID: 25557055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profile after activation of RIG-I in 5'ppp-dsRNA challenged DF1.
    Chen Y; Xu Q; Li Y; Liu R; Huang Z; Wang B; Chen G
    Dev Comp Immunol; 2016 Dec; 65():191-200. PubMed ID: 27450445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.